Two cases of IV tocilizumab treatment of COVID-19 in pregnancy

Although tocilizumab has been shown to be efficacious in treating severe cases of COVID-19, data relating to the safety of tocilizumab use in pregnancy remain limited. A group of researchers from Sheikh Khalifa Medical City in Abu Dhabi have recently published two case reports describing tocilizumab treatment of COVID-19 in pregnancy. More details can be found here. Photo by Mufid Majnun on Unsplash

» Read more

Women’s perceptions of the risks associated with dental imaging during pregnancy

Dental public health researchers from Saudi Arabia have conducted a survey to assess women’s perceptions of the risks associated with dental imaging during pregnancy. The study found many of the respondents believed there was a high risk of congenital malformation due to dental imaging, highlighting a need for improved education about radiation risks in pregnancy. More information can be found […]

» Read more

New study investigates the risk of severe cardiac malformation following antidepressant use

Researchers from Aarhus University Hospital have conducted a population-based linkage of national administrative healthcare utilisation datasets to assess the risk of severe cardiac malformation following maternal first trimester antidepressant use. Interesting findings were described for the venlafaxine exposed cohort. Further information can be found here. Photo by Nastya Dulhiier on Unsplash

» Read more

Neonatal outcomes following maternal SARS-CoV-2 infection in pregnancy

Researchers from 11 academic or community hospitals in Massachusetts have published the results of a multi-centre cohort study describing the clinical outcomes of neonates born to mothers who tested positive for CV-19 in pregnancy, and the clinical and sociodemographic factors associated with positive neonatal test results. More information can be found here. Photo by Peter Oslanec on Unsplash

» Read more

Systematic review and meta-analysis quantifies the risk of birth defects following exposure to antithyroid drugs

Researchers from the University of Dundee, University of South Denmark and the University of Oslo (ENTIS Associate Member Prof Hedvig Nordeng) have collaborated on a meta-analysis examining malformation risks following maternal antithyroid drug use, calculating absolute risks for each of the different medication exposure groups. More information can be found here. Photo by Olga DeLawrence on Unsplash

» Read more
1 … 20 21 22 23 24 … 32